0130: Plasma interleukin-18 levels depend on hypertriglyceridemic waist phenotype and gender in patients with arterial hypertension - 07/02/15
Résumé |
The aim our study was to investigate cardiometabolic risk factors and plasma interleukin-18 (IL-18) levels in relationships with hypertriglyceridemic waist phenotype (HTGW) depend on gender of patients with arterial hypertension (AH).
Methods |
Anthropometric parameters, carbohydrate and lipid metabolism, circulating IL-18 levels in 101 patients with AH (men (n=45; 44.6%) and women (n=56; 55.4 %) aged 32-80 years) were examined. HTGW was defined as a waist circumference (WC) of 90cm and more in male, and 85cm and more in female, and a triglyceride level of 1.7mmol/L or more. Patients were categorized into 3 phenotype groups: 1st with hypertriglyceridemia and normal WC, 2nd with normal triglyceride level and increased WC, 3rd with HTGW.
Abstract 0032 - Figure: Variability analysis
Abstract 0032 - Figure: Variability analysis
Results |
The patients of 3rd group characterized by maximum blood pressure levels. Body mass index (BMI) in 3rd group was also highest (31.05±0.61kg/m2) vs 1st (23.95±0.91kg/m2) and 2nd one (30.21±1.00kg/m2). Fasting insulin levels were elevated in patients of 3rd group with HTGW (14.66±0.95mkU/ml), and same in 1st (12.52±2.79mkU/ml) and 2nd (12.31±1.41mkU/ml) groups.
IL-18 - pro-inflammatory cytokine levels in 3rd group were 176.97± 2.38pg/ml, that was statistically higher in comparison with 1st (167.73±7.21pg/ml), and 2nd group (172.40±5.61pg/ml; p<0.05). Plasma IL-18 in 2nd group was higher in men (172.40±5.61 pg/mg) vs women (169.53±7.04pg/ml; p<0.05); whereas in 1st group women characterized by significantly higher IL-18 content (169.00±1.11pg/ml) compared with men (160.83±9.35pg/ml; p<0.05). The same tendency was found in group 3 with HTGW phenotype presence where IL-18 content in women (180.62±2.93pg/ml) exceed cytokine level in men (167.76±3.52pg/ml; p<0.05).
Conclusions |
Our results can suggest that HTGW phenotype is associated with more significant in women elevation of pro-inflammatory activity, high glucometabolic risk and atherogenic metabolic risk profile and can be used as a simple and inexpensive marker to help identify patients with high cardiometabolic risk.
Le texte complet de cet article est disponible en PDF.Vol 7 - N° 1
P. 80 - janvier 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
